fda restrictions on bpc-157 compounding may take an important step toward opening the peptide floodgates this week Peptides in the Limelight: US

Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval

SKU: 77639743751 · From clintoncounty708.com